Starling Oncology STLN
NASDAQ STLN
$5.95 -0.14 (-2.22%)
As of: Sep 3, 2026 · 3:37 PM EDT

Starling Oncology (STLN) Share-based Compensation (2021 - 2026)

Analysis

Starling Oncology (STLN) Share-based Compensation (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 HCA Healthcare 90.73 Bn 89.71 Bn 15.19 Bn 85.00 Mn
2 Tenet Healthcare 22.05 Bn 19.88 Bn 4.45 Bn -3.00 Mn
3 Encompass Health 12.13 Bn 12.00 Bn 1.34 Bn -
4 Davita 11.78 Bn 11.09 Bn 1.16 Bn 659,000.00
5 Universal Health Services 10.12 Bn 9.98 Bn 3.29 Bn 199.20 Mn
6 Ensign 9.97 Bn 9.64 Bn 306.24 Mn 38.43 Mn
7 Chemed 6.91 Bn 6.87 Bn 221.47 Mn 9.05 Mn
8 Pacs 6.73 Bn 6.57 Bn 338.46 Mn 25.83 Mn
9 Concentra Group Holdings Parent 4.30 Bn 4.14 Bn 192.10 Mn 4.13 Mn
10 Starling Oncology 613.55 Mn 572.46 Mn 27.17 Mn 1.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.07 Mn
Mar 31, 2026 1.69 Mn
Dec 31, 2025 1.32 Mn
Sep 30, 2025 1.02 Mn
Jun 30, 2025 752,000.00
Mar 31, 2025 1.46 Mn
Dec 31, 2024 1.29 Mn
Sep 30, 2024 2.39 Mn
Jun 30, 2024 3.39 Mn
Mar 31, 2024 4.09 Mn
Dec 31, 2023 4.08 Mn
Sep 30, 2023 4.66 Mn
Jun 30, 2023 4.11 Mn
Mar 31, 2023 4.97 Mn
Dec 31, 2022 6.07 Mn
Sep 30, 2022 6.55 Mn
Jun 30, 2022 6.51 Mn
Mar 31, 2022 8.55 Mn
Dec 31, 2021 24.38 Mn
Sep 30, 2021 59,000.00